—Is it asthma? Is it chronic obstructive pulmonary disease? In a genome-wide association study, researchers in the U.K. have determined signals that are associated with both diseases. Here are the ...
COPD study initiation expands WIN378 development into a second major respiratory diseaseWIN378 is currently being evaluated in the Phase 2/3 ...
Communities impacted by increased wildfire activity and smoke can use a population health-based action plan to help alleviate health risks, particularly for those with chronic obstructive pulmonary ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") today announced that its partner Windward Bio has dosed the first patients in the Phase 2 SIRIUS study of ...
Your breath could hold clues to your health, researchers say — and they have developed a "smart mask" to tap into them. Wei Gao, professor of medical engineering at the California Institute of ...
HONOLULU -- Pulmonologists couldn't agree whether it was time to drop asthma/chronic obstructive pulmonary disease (COPD) overlap (ACO) as a distinct airway disease, allowing no end to this ...
A high-pitched whistling sound when you breathe is the first tip-off that air is fighting to make its way into or out of your lungs. That sound is aptly named wheezing, and it is something that people ...
The study aims to assess the safety, pharmacodynamics, pharmacokinetics and tolerability of HBM9378 for COPD.
Lupin has announced a strategic collaboration with Spanish pharmaceutical company Laboratorios ERN S.A. for the launch of Luforbec (beclometasone/formoterol) 100/6, a fixed-dose combination inhaler.
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results